Results 41 to 50 of about 53,718 (156)
Abstract Introduction Vascular disease is a common cause of dementia, and often coexists with other brain pathologies such as Alzheimer's disease to cause mixed dementia. Many of the risk factors for vascular disease are treatable. Our objective was to review evidence for diagnosis and treatment of vascular cognitive impairment (VCI) to issue ...
Eric E. Smith +12 more
wiley +1 more source
Nebivolol hydrochloride (NEB) is a 3rd generation highly selective β1-blocker with antihypertensive properties, the elimination half-life is about 10 hrs and the oral bioavailability is about 12%.
Esraa Ghazy +3 more
doaj +1 more source
Samples of C. ramosus and D. platypus were collected from Hurgada, the Red Sea during June-August 2018. Samples were transported to the lab at the University of Alexandria, Egypt. This study aims to describe the embryogenesis of C.
Ibrahim Gaber +2 more
doaj +1 more source
DEVELOPMENT AND VALIDATION OF HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHY METHOD FOR SIMULTANEOUS ESTIMATION OF NEBIVOLOL HYDROCHLORIDE AND CILNIDIPINE [PDF]
Objective: The proposed method describes method development and validation of nebivolol hydrochloride and cilnidipine in combined pharmaceutical tablet dosage form by high-performance thin-layer chromatography (HPTLC) having adequate specificity ...
ATUL NIKAM +5 more
core +1 more source
A simple, rapid, sensitive and economic spectrofluorimetric method has been developed and validated for determination of some β-adrenergic blocking agents namely; betaxolol hydrochloride (BTX), carvedilol (CAR), labetalol hydrochloride (LBT), nebivolol ...
Derayea Sayed M +3 more
doaj +1 more source
The present work was undertaken with the aim to develop and validate a rapid and consistent RP-HPLC method in which the peaks will be appear with short period of time as per ICH Guidelines.The separation was achieved on a stainless steel analytical ...
Ashutosh Kumar +3 more
core +1 more source
Objective: The objective of the present investigation was to design and characterize a mucoadhesive buccal patch of Nebivolol hydrochloride in order to administer a small dose of a drug to treat hypertension effectively and thereby avoiding disadvantages such as patient noncompliance and low bioavailability. Methods: The buccal patches were ...
CLINTON JOSE +5 more
openaire +2 more sources
COMPUTATIONAL TOOLS ASSISTED FORMULATION OPTIMIZATION OF NEBIVOLOL HYDROCHLORIDE LOADED PLGA NANOPARTICLES BY 32 FACTORIAL DESIGNS [PDF]
Objective: The aim of the present study was to formulate and optimize the PLGA polymeric nanoparticle of Nebivolol Hydrochloride for sustain release of drug Methods: The drug-excipients interaction was explored by molecular docking studies by in silico ...
P. JAMES, JAINEY +5 more
core +1 more source
FORMULATION AND EVALUATION OF S-(-)-AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE TABLETS [PDF]
The objective of the present study was to develop a tablet formulation of S-(-)-amlodipine besylate chiral separation drug and nebivolol hydrochloride for better management of hypertension, while reducing or avoiding undesirable adverse effects, such as ...
core
Stability-Indicating HPTLC Method for Determination of Nebivolol Hydrochloride and Valsartan
An accurate, sensitive, rapid and precise HPTLC method for analysis of Nebivolol Hydrochloride and Valsartan in the combination has been developed and validated. Literature survey reveals few stability indicating methods for Nebivolol Hydrochloride and Valsartan as single drugs.
C. Damle Mrinalini +2 more
openaire +1 more source

